Actualités sur Santè / Médecine
- plus
Hitachi Medical Systems Europe Holding AG
2Hitachi and Centre Léon Bérard cancer center in Lyon to launch a research collaboration in the fight against cancer with AI
plusThe International Osteoporosis Foundation (IOF)
2IOF: A fracture every 3 seconds worldwide - That's osteoporosis
plusVersameb raises CHF 6.4 million in Seed C round and strengthens the team
plusA pancreatic and colorectal cancer trial initiated to address the needs of patients with Immune Checkpoint Inhibitor-resistant disease by combining IAP antagonist Debio 1143 with Keytruda®
Lausanne (ots) - First patient enrolled in the investigator initiated CATRIPCA study (Combination with an IAP Antagonist To Reverse Immune resistance in Pancreatic and Colorectal Adenocarcinoma) at the Léon Bérard Cancer Center in Lyon France Debiopharm (www.debiopharm.com) announced today the first patient ...
plusEASL European Association for the study of the Liver
2Obesity epidemic results in Non-Alcoholic Fatty Liver Disease (NAFLD) becoming the most common cause of liver disease in Europe
plusUnited Nations Political Declaration on Universal Health Coverage finally has some teeth / Oral health included in global health agenda
Geneva, Switzerland (ots) - FDI World Dental Federation (FDI) welcomes the long overdue commitment to strengthening oral health in the UN Political Declaration on Universal Health Coverage (UHC) (http://ots.ch/juoOII). The declaration will be officially adopted by world leaders at the UN High-Level Meeting on UHC on ...
plusHelsana report shows: Medical services on the rise
Zürich (ots) - The "Volume Report" published today by Helsana elucidates the development of medical treatments. In Switzerland, increasing numbers of patients make use of medical treatments. As a result there is an increased need for coordination. General practitioners have less and less time to perform this role. The report finds great potential to meet these coordination needs in other health occupations. In its latest ...
plusFDI World Dental Federation and Smile Train launch project to improve oral health of children with clefts: the most common birth difference of the face and mouth
plus- 2
New FDI World Dental Federation care pathway promotes dentist-patient collaboration to manage partial tooth loss
plus Debiopharm successfully completes randomized Phase II study for IAP antagonist Debio 1143 in high risk head & neck cancer patients
Lausanne, Switzerland (ots) - Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced positive topline results across clinical endpoints following the completion of the two-year follow-up period of its double-blind, randomized Phase II study of Debio 1143 in high-risk, previously untreated ...
plusPoor oral health severely impacts training and athletic performance, says FDI World Dental Federation
Geneva (ots) - If they want to win, elite and amateur athletes need to make their oral health a top priority. FDI World Dental Federation (FDI) couldn't agree more. Today the organization released a series of sports dentistry resources for amateur and elite athletes, dentists and sports medicine physicians, and sports organizations. The release coincides with a packed ...
plusDebiopharm expands its Immuno-Oncology development program for Debio 1143, with the first IAP inhibitor/nivolumab combination trial
Lausanne, Switzerland (ots) - First patient enrolled in SMARTPLUS-106, a Phase lb/II study in patients failing prior PD-1/PD-L1 treatment in selected solid tumors Debiopharm (www.debiopharm.com) announced today the first patient enrolled in SMARTPLUS-106, an exploratory study investigating the safety and efficacy of ...
plusMedical technology sector suffers from legal uncertainty / Swiss Medtech gives recommendation to Swiss medical device manufacturers
plusSecurity of supply and politics - a conflict? / Third national Swiss Medtech MDR&IVDR Conference
plusGenePOC obtains FDA clearance for its GenePOC(TM) Strep A test in the US
Québec, Canada (ots) - GenePOC Inc., member of the Debiopharm Group, announces its third test to be cleared by the FDA, the GenePOC Strep A assay, to be used with the revogene(TM) device. About Group A Streptococcus (GAS) infection GAS is the most common bacterial etiology of pharyngitis accounting for 15 to 30% cases in children and 5 to 20% in adults[1]. In the ...
plusUK Schools Rank Last in Providing Oral Health Education, FDI Survey of 13 Countries Says
plus- 2
FDI: Endodontics white paper calls for treatment to consider impact on patient health and well-being
plus Hitachi Medical Systems Europe Holding AG
2Hitachi Medical Systems Europe presents the next generations in Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) at the European Society of Radiology, February 28, 2019
plusHitachi Medical Systems Europe Holding AG
3Good health runs in families / Hitachi Medical Systems Europe welcomes five new family members to the diagnostic ultrasound series at the European Society of Radiology
plus- 2
ForaCare Suisse AG forms service-oriented partnership with B. Braun
plus Debiopharm Group regains the commercial rights to Trelstar® (Triptorelin pamoate) and looks for new partners in North America
Lausanne, Switzerland (ots) - Debiopharm and Allergan agree to transition the rights to commercialize Trelstar to new licensees. Debiopharm is in advanced discussion with a potential partner in Canada and is engaged in a bidding process for US rights. Debiopharm Group(TM) (Debiopharm - www.debiopharm.com), a ...
plusNEMIS Technologies Ltd. Successfully Closes First Seed Financing Round / Swiss Diagnostic Startup Closes Seed Financing Round of CHF 3 Million Within the First Year
plusHitachi Medical Systems Europe Holding AG
2Hitachi Medical Systems Europe introduces the third generation of non-invasive intracardiac blood flow visualization technology, at EuroEcho Imaging 2018
plusEUR 500 M class action lawsuit against NOLOTIL painkiller manufacturer Boehringer and distributers / International press conference, Barcelona, 28th November 2018
Barcelona (ots) - The medication NOLOTIL is one of the most widely distributed painkillers worldwide. However, its use has been prohibited in some countries because of adverse side-effects. To this day, NOLOTIL is still prescribed for acute pain in Spain, despite the potentially severe side-effects. The incidence of ...
plusSAKK - Swiss Group for Clinical Cancer Research
The GIST Group Switzerland, the support group for patients with gastrointestinal stromal tumor, has awarded its science prize for the ninth time.
plusThe International Osteoporosis Foundation (IOF)
Don't Miss the Signs of a Breaking Spine, Warns IOF
plus- 3
Revolutionary Phonak Marvel hearing aids: the ultimate combination of exceptional sound quality and universal Bluetooth® connectivity
plus European Society for Medical Oncology (ESMO)
Breast cancer patients use Twitter as a non-medical forum to share their experiences
Lugano/Munich (ots) - Twitter is a place where many cancer patients share and discuss their experiences, a study at the ESMO 2018 Congress reveals, based on analysis of the contents of over 6,000 tweets and retweets about breast cancer. The study was part of a larger, multidisciplinary project to observe the presence of different diseases on social media. The data ...
plusIndia hosts the Mahatma Gandhi International Sanitation Convention / 29th September to 2nd October 2018, New Delhi
New Delhi (ots) - Ministers and sanitation sector leaders from around the world will convene this month at the Mahatma Gandhi International Sanitation Convention (MGISC) in New Delhi. Hosted by the Government of India, this event will be an opportunity for delegates to exchange sanitation successes and best ...
plus